Company / Return on Assets (ROA)
Outlook Therapeutics, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-405.5%
FY2025
5-year range
-405.5% / -174.3%
FY2021-FY2025
Trend
-131.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 6 years, ranging from -405.5% in FY2025 to -174.3% in FY2018.
Based on SEC 10-K filings.
-405.5% in FY2025 with a 5-year CAGR of -230.6%.
Declined from -175.6% to -405.5% over the past 6 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -230.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 131.8% year-over-year.
- Peak return on assets (roa) was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -405.5% | -131.8% |
| FY2020 | -175.0% | +0.4% |
| FY2019 | -175.6% | -0.7% |
| FY2018 | -174.3% | +32.2% |
| FY2017 | -257.1% | -28.6% |
| FY2016 | -199.9% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026